All systems operational
Q3 2026

A multidisciplinary pulmonary rehabilitation pathway for hospitalized patients with chronic lung disease and post-COVID syndrome: a prospective controlled cohort study

Aibo Zheng · Kai Sun · Shengjun Ma · Yan Jin · Wenjun Li · Zhiyu Chen · Feizhong Gong · Juan Pen · Xin Ming · Aibo Zheng
10.1186/s43168-026-00587-3 387 Views 0 Citations
0
Citations
387
Views
Abstract

Abstract

Background
Patients with chronic lung disease (CLD) and post-COVID syndrome suffer from multidimensional impairment that is often incompletely addressed by pharmacotherapy alone. We evaluated a ward-based multidisciplinary pathway integrating pharmacotherapy, psychological support, and pulmonary rehabilitation.


Methods

In this prospective controlled cohort study, 360 hospitalized patients with CLD and post-COVID syndrome received integrated multidisciplinary care (
n
 = 120) or usual care (
n
 = 240). The primary outcomes were changes in PaCO₂, FEV₁% predicted, and CT-assessed residual radiological abnormality extent. Patient-reported outcomes, functional capacity, inflammation, and 6-month follow-up data were also assessed. Analyses used adjusted regression and IPTW.



Results

Integrated care was associated with greater improvements in the three primary outcomes: PaCO₂, adjusted β − 0.98 mmHg (95% CI − 1.21 to − 0.75;
P
 < 0.001); FEV₁% predicted, adjusted β 2.35% points (95% CI 1.53 to 3.17;
P
 < 0.001); and CT-assessed residual abnormality extent, adjusted β − 0.55% points (95% CI − 0.87 to − 0.24;
P
 < 0.001). Integrated care was also associated with greater improvements in SGRQ score, SAS score, 15-minute walking distance, CRP, ESR, and sleep-quality score. The composite early clinical benefit rate was higher in the integrated-care group than in the usual-care group, with an adjusted OR of 1.91 (95% CI 1.21 to 3.01;
P
 = 0.006). At 6 months, sleep quality was better and symptom-related medication use was lower, while rehospitalisation, acute exacerbation, and CT progression rates were similar between groups.



Conclusions
The integrated pathway was associated with broader short-term clinical improvement and lower symptom-related treatment burden at follow-up, although rehospitalisation, acute exacerbation, and CT progression rates were similar between groups.

Cite this Article (APA)
Aibo, Z., Kai, S., Shengjun, M., Yan, J., Wenjun, L., Zhiyu, C., Feizhong, G., Juan, P., Xin, M., Aibo, Z. (2026). A multidisciplinary pulmonary rehabilitation pathway for hospitalized patients with chronic lung disease and post-COVID syndrome: a prospective controlled cohort study. Egyptian Journal of Bronchology. https://doi.org/10.1186/s43168-026-00587-3
Related Papers
Criteria and potential predictors of severity in patients with COVID-19
Niveen E. Zayed; Ahmad Abbas; Samah Mohamad Lutfy · 2022
24
cites
393
Serum interleukin-6 in chronic obstructive pulmonary disease patients and its relation to severity a…
Fatma G. M. Hussein; Randa S. Mohammed; Rasha A. Khattab; Laila A. Al-Sharawy · 2022
24
cites
391
Predictors of severity and mortality in COVID-19 patients
Hebatallah Hany Assal; Hoda M. Abdel-hamid; Sally Magdy; Maged Salah; Asmaa Ali; · 2022
19
cites
390
Protective mechanism of quercetin and its derivatives in viral-induced respiratory illnesses
Wahyu Choirur Rizky; Muhammad Candragupta Jihwaprani; Mazhar Mushtaq · 2022
10
cites
393
Access
View Full Text via DOI
Published in
ISSN 1687-8426
Quartile Q3
AMS Score 82
Field Medicine & Health Sciences
Publisher Springer (Biomed Central Ltd.)
Country 🇪🇬 Egypt
View Journal Profile →
Authors
Publication Details
Year 2026
Language English
Added 14 Aug 2026